Engineered T Cells Bypass Death Signaling and Bolster Immunotherapy

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2019-033
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T Cells

Clinical Cancer Research
Cancer ResearchOncology
2009English

Inhibition of AKT Signaling Uncouples T Cell Differentiation From Expansion for Receptor-Engineered Adoptive Immunotherapy

JCI insight
Medicine
2017English

Regulatory T Cells in Cancer Immunotherapy

Current Opinion in Immunology
AllergyImmunology
2014English

Regulatory T Cells in Cancer Immunotherapy

Cell Research
Cell BiologyMolecular Biology
2016English

Extrathymic Generation of Tumor-Specific T Cells From Genetically Engineered Human Hematopoietic Stem Cells via Notch Signaling

Cancer Research
Cancer ResearchOncology
2007English

Treating Cancer With Genetically Engineered T Cells

Trends in Biotechnology
BioengineeringBiotechnology
2011English

Armed T Cells With CAR for Cancer Immunotherapy

Science China Life Sciences
GeneticsMolecular BiologyEnvironmental ScienceBiochemistryBiological SciencesAgricultural
2016English

Anti-Car-Engineered T Cells for Epitope-Based Elimination of Autologous CAR T Cells

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Signaling Microdomains in T Cells

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy